We use cookies for a better user experience. Read our Privacy Policy

I Agree

Varicose Veins Treatment Market

Varicose Veins Treatment Market (Product: Ablation Devices, Catheters/Kits for Sclerotherapy & Adhesion Injection, Compression Devices/Garments, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Varicose Veins Treatment Market Outlook 2031

  • The global varicose veins treatment market was valued at US$ 1.5 Bn in 2021
  • The global market is projected to grow at a CAGR of 4.8% from 2022 to 2031
  • The global varicose veins treatment market is anticipated to reach more than US$ 2.4 Bn by 2031

Analysts’ Viewpoint on Varicose Veins Treatment Market Scenario

The global varicose veins treatment market is constantly evolving, as prominent players adopt growth strategies such as mergers & acquisitions, new product launches, and partnerships. Growth of the global varicose veins treatment market can be ascribed to rise in prevalence and awareness of varicose veins coupled with favorable reimbursement policies. Preference for compression devices, stockings, and garments has increased for varicose veins treatment. These devices help reduce symptoms of venous insufficiency and improve blood circulation by exerting gentle pressure on the legs. Venture funding and geographical expansions are likely to create significant opportunities for existing market participants and new market entrants in the near future. The global varicose veins treatment devices market players should focus on continued investment in R&D to introduce innovative products in the market.

varicose veins treatment market

Varicose Veins Treatment Market Introduction

Medical treatments for varicose veins include self-care such as compression stockings, exercise, and medical procedures/surgeries along with devices. Various methods such as endovenous ablation (a varicose veins surgery), sclerotherapy/adhesion injection, ligation/stripping, and supportive treatment are used for varicose veins treatment.

An article published in the Journal of Family Medicine and Primary Care stated that the prevalence of varicose veins varies from 10% to 60% of the population across the world. Varicose veins is a common chronic venous disorder that affects 20% to 60% of adults, globally. The prevalence is around 4,500 cases per 100,000 individuals and around 23% of adults have varicose veins in the U.S. The incidence is higher in Asia Pacific at 30% than in the West.

Rise in prevalence of small and greater saphenous vein, reticular varicose veins, and genital area varicose veins have induced people to be more aware and educated about varicose veins warning signals and the importance of prompt response. Technological advancements in varicose veins treatment devices propel the global market. Radiofrequency (RF) endovenous ablation is one of the several minimally invasive treatments used for varicose veins. RF procedure involves the use of ultrasound to guide a radiofrequency catheter.

Surgical removal is one of the several treatments used for varicose veins. In the procedure, infrared medical vein finders are used to draw a map of veins, arteries, and tissues to avoid complications during treatment.

Mechanochemical Ablation (MOCA) is a non-thermal, non-tumescent technique used for the treatment of incompetent saphenous vein. Such technological advancements in varicose veins treatment are driving the market. Additionally, in August 2019, Surekha Varicose Veins Clinic in Mumbai launched India’s first-ever Cryo Laser and Cryo Sclerotherapy (CLaCS) for the treatment of small varicose veins in the leg and spider veins (spider vein treatment). Sclerotherapy is a minimally invasive procedure used for spider vein treatment, usually in the legs.

Request a sample to get extensive insights into the Varicose Veins Treatment Market

COVID-19 Impact on Global Varicose Veins Treatment Market

COVID-19 has had a negative effect on the varicose veins treatment devices market. Several varicose veins surgeries were postponed or canceled, as these fall under the elective or non-urgent procedures category. Reduction in the number of surgeries or procedures for the treatment of varicose veins due to traveling restrictions also hit product sales. For instance, AngioDynamics' net sales declined by 2.4% in 2020, as compared to 2019. Venous registry volumes reduced fivefold in India in the first quarter of 2020, as compared to a similar period in 2019. In 2020, varicose veins treatment surgeries declined by 30% in public hospitals in Australia, as compared to those in 2019. Recently, clinics and hospitals have resumed services for non-emergent cases and backlogged procedures for varicose veins. This, in turn, is anticipated to drive demand for devices in the near future.

Growing Emphasis on Appearance Improvement of Varicose Veins

In terms of product, the compression devices/garments segment held the largest global varicose veins treatment market share in 2021. The segment is projected to grow at a rapid pace during the forecast period. This is ascribed to increase in the use of compression stockings to effectively manage and treat varicose veins in the early stages. Preference for compression stockings for varicose veins treatment is on the rise, as these help to ease symptoms and pain and improve the appearance of varicose veins. This is expected to drive the segment during the forecast period.

Rise in Preference for Compression Stockings to Drive Supportive Treatment Segment

The supportive treatment segment held a prominent share of the global varicose veins treatment market in 2021, and the trend is anticipated to continue during the forecast period. This is ascribed to increase in preference for compression stockings and rise in consumption along with the repetitive purchase of compression socks. Compression stockings have been a standard treatment for varicose veins for several decades and are still prescribed as the first-line therapy to manage symptoms and prevent the progression of chronic venous insufficiency.

Increase in Admissions to Hospitals & Ambulatory Surgery Centers for Venous Insufficiency Treatment

The rate of hospitalization for varicose veins treatment and the range of services offered by hospitals at a single site is on the rise. Ambulatory Surgery Centers (ASCs) can improve quality and customer service, while simultaneously reducing healthcare costs. The ASC vertical is ahead of the curve in identifying favorable avenues to improve healthcare delivery. Increase in the number of hospitals and ASCs along with comparatively higher performance and adoption of varicose veins surgeries in these settings is expected to augment the segment.

Regional Analysis of Global Varicose Veins Treatment Market

North America accounted for the largest share of the global varicose veins treatment market in 2021, and the trend is expected to continue during the forecast period. Growth of the market in the region is ascribed to rise in the burden of varicose veins and higher rate of adoption of varicose vein treatment devices and procedures in the U.S. and Canada are also boosting the market in North America. The region also has a robust presence of prominent manufacturers, such as AngioDynamics, Inc., Boston Scientific Corporation, DJO, LLC, Viatris, Inc., and Teleflex Incorporated, which facilitates early market access and easier availability of products.

Asia Pacific is likely to be a lucrative market during the forecast period due to surge in geriatric population, increase in incidence of varicose veins, rise in awareness about advanced treatment options, and surge in adoption of minimally invasive procedures for the treatment of varicose veins. For instance, an article published in China Daily in July 2021 indicated that around 120 million patients in China suffered from varicose veins of the lower extremities in 2021, of which more than 80 million were women. The primary treatments followed in the country are drug-based therapy, compression therapy, sclerotherapy (injections that destroy abnormal blood vessels), and varicose veins surgery.

Analysis of Key Players in Global Varicose Veins Treatment Market

The varicose veins treatment market research report concludes with the company profiles section that includes key information about the major players in the global varicose veins treatment market. Market participants focus on strategies such as new product launches, mergers & acquisitions (M&As), and partnerships to strengthen their market position. AngioDynamics, Inc., Boston Scientific Corporation (BTG International Inc.), DJO, LLC (Enovis Corporation), Essity Aktiebolag (publ) (BSN Medical), F Care Systems NV, Medtronic plc, Miravas (IPSA Group), Mylan N.V. (Viatris Inc.), SIGVARIS Group, Teleflex Incorporated, VVT Medical, and WONTECH Co., Ltd. are the prominent players operating in the global market.

Request a custom report on Varicose Veins Treatment Market

Key Developments in Global Varicose Veins Treatment Market

In June 2022, VVT Medical signed a distribution agreement with Getz Healthcare, a medical technology distributor in Asia Pacific. According to the terms of the agreement, Getz will distribute VVT Medical’s products in Australia, New Zealand, and Hong Kong.

In November 2020, Pfizer, Inc. completed the transaction to spin off its Upjohn Business and combined it with Mylan N.V. to form Viatris, Inc. The merger was aimed to form a new name that would differentiate the new company and explain the company’s position in the global healthcare industry.

In October 2019, AngioDynamics, Inc. acquired Eximo Medical, Ltd., a medical device company, and its proprietary 355nm wavelength laser-technology platform, to bring a remarkable, foundational technology to the company’s portfolio, which would change the way caregivers deliver treatment to patients with Peripheral Artery Disease (PAD). With this acquisition, the company expanded its laser device product portfolio.

Each of these players has been profiled in the varicose veins treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Varicose Veins Treatment Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 1.5 Bn

Market Forecast Value in 2031

More than US$ 2.4 Bn

Compound Annual Growth Rate (CAGR)

4.8%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value & Units for Volume

Market Analysis

It includes segment analysis as well as regional level analysis. The volume analysis has been provided for the product segment at global and regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Ablation Devices
      • Radiofrequency Ablation / Thermal Ablation
      • Laser Ablation Devices
      • Ultrasound Ablation Devices
    • Catheters / Kits for Sclerotherapy & Adhesion Injection
    • Compression Devices / Garments
    • Others
  • Treatment Type
    • Endovenous Ablation
    • Sclerotherapy/Adhesion Injection
    • Ligation/Stripping
    • Supportive Treatment
  • Disease Type
    • Greater Saphenous Varicose Veins
    • Small Saphenous Varicose Veins
    • Others
  • End-user
    • Hospitals & Ambulatory Surgical Centers
    • Specialty Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • AngioDynamics, Inc.
  • Boston Scientific Corporation (BTG International Inc.)
  • DJO, LLC (Enovis Corporation)
  • Essity Aktiebolag (publ) (BSN Medical)
  • F Care Systems NV
  • Medtronic plc
  • Miravas (IPSA Group)
  • Mylan N.V. (Viatris, Inc.)
  • SIGVARIS Group
  • Teleflex Incorporated
  • VVT Medical
  • WONTECH Co., Ltd.

Customization Scope

Available upon request

Pricing

Available upon request

Varicose Veins Treatment Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global varicose veins treatment market in 2021?

The global varicose veins treatment market was valued at US$ 1.5 Bn in 2021

How big will be the global varicose veins treatment market by 2031?

The global varicose veins treatment market is projected to reach more than US$ 2.4 Bn by 2031

What will be the CAGR of the global varicose veins treatment market during the forecast period (2022–2031)?

The global varicose veins treatment market is anticipated to grow at a CAGR of 4.8% from 2022 to 2031

Which are the prominent trends that affect market growth?

Rise in prevalence and awareness about varicose veins, favorable reimbursement policies, and technological advancements in varicose veins treatment

What was the market share of the leading segment of the global varicose veins treatment market?

The compression devices/garments segment accounted for more than 48% share of the global varicose veins treatment market in 2021

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global varicose veins treatment market during the forecast period

Who are the prominent players in the global varicose veins treatment market?

AngioDynamics, Inc., Boston Scientific Corporation (BTG International Inc.), DJO, LLC (Enovis Corporation), Essity Aktiebolag (publ) (BSN Medical), F Care Systems NV, Medtronic plc, Miravas (IPSA Group), Mylan N.V. (Viatris Inc.), SIGVARIS Group, Teleflex Incorporated, VVT Medical, and WONTECH Co., Ltd.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Varicose Veins Treatment Market

4. Market Overview

    4.1. Overview

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunities

5. Key Insights

    5.1. Key Industry Events

    5.2. Epidemiology of Varicose Veins Globally with Key Countries

    5.3. Overview of Treatment and Management of Varicose Veins

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Varicose Veins Treatment Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value & Volume Forecast, by Product, 2017–2031

        6.3.1. Ablation Devices

            6.3.1.1. Radiofrequency Ablation/Thermal Ablation

            6.3.1.2. Laser Ablation Devices

            6.3.1.3. Ultrasound Ablation Devices

        6.3.2. Catheters/Kits for Sclerotherapy & Adhesion Injection

        6.3.3. Compression Devices/Garments

        6.3.4. Others

    6.4. Market Attractiveness Analysis, by Product

7. Global Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Treatment Type, 2017–2031

        7.3.1. Endovenous Ablation

        7.3.2. Sclerotherapy/Adhesion Injection

        7.3.3. Ligation/Stripping

        7.3.4. Supportive Treatment

    7.4. Market Attractiveness Analysis, by Treatment Type

8. Global Varicose Veins Treatment Market Analysis and Forecast, by Disease Type

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Disease Type, 2017–2031

        8.3.1. Greater Saphenous Varicose Veins

        8.3.2. Small Saphenous Varicose Veins

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by Disease Type

9. Global Varicose Veins Treatment Market Analysis and Forecast, by End-user

    9.1. Introduction & Definition

    9.2. Key Findings/Developments

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Hospitals & Ambulatory Surgical Centers

        9.3.2. Specialty Clinics

        9.3.3. Others

    9.4. Market Attractiveness Analysis, by End-user

10. Global Varicose Veins Treatment Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness Analysis, by Region

11. North America Varicose Veins Treatment Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value & Volume Forecast, by Product, 2017–2031

        11.2.1. Ablation Devices

            11.2.1.1. Radiofrequency Ablation/Thermal Ablation

            11.2.1.2. Laser Ablation Devices

            11.2.1.3. Ultrasound Ablation Devices

        11.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection

        11.2.3. Compression Devices/Garments

        11.2.4. Others

    11.3. Market Value Forecast, by Treatment Type, 2017–2031

        11.3.1. Endovenous Ablation

        11.3.2. Sclerotherapy/Adhesion Injection

        11.3.3. Ligation/Stripping

        11.3.4. Supportive Treatment

    11.4. Market Value Forecast, by Disease Type, 2017–2031

        11.4.1. Greater Saphenous Varicose Veins

        11.4.2. Small Saphenous Varicose Veins

        11.4.3. Others

    11.5. Market Value Forecast, by End-user, 2017–2031

        11.5.1. Hospitals & Ambulatory Surgical Centers

        11.5.2. Specialty Clinics

        11.5.3. Others

    11.6. Market Value Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1. By Product

        11.7.2. By Treatment Type

        11.7.3. By Disease Type

        11.7.4. By End-user

        11.7.5. By Country

12. Europe Varicose Veins Treatment Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value & Volume Forecast, by Product, 2017–2031

        12.2.1. Ablation Devices

            12.2.1.1. Radiofrequency Ablation/Thermal Ablation

            12.2.1.2. Laser Ablation Devices

            12.2.1.3. Ultrasound Ablation Devices

        12.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection

        12.2.3. Compression Devices/Garments

        12.2.4. Others

    12.3. Market Value Forecast, by Treatment Type, 2017–2031

        12.3.1. Endovenous Ablation

        12.3.2. Sclerotherapy/Adhesion Injection

        12.3.3. Ligation/Stripping

        12.3.4. Supportive Treatment

    12.4. Market Value Forecast, by Disease Type, 2017–2031

        12.4.1. Greater Saphenous Varicose Veins

        12.4.2. Small Saphenous Varicose Veins

        12.4.3. Others

    12.5. Market Value Forecast, by End-user, 2017–2031

        12.5.1. Hospitals & Ambulatory Surgical Centers

        12.5.2. Specialty Clinics

        12.5.3. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Italy

        12.6.5. Spain

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1. By Product

        12.7.2. By Treatment Type

        12.7.3. By Disease Type

        12.7.4. By End-user

        12.7.5. By Country/Sub-region

13. Asia Pacific Varicose Veins Treatment Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value & Volume Forecast, by Product, 2017–2031

        13.2.1. Ablation Devices

            13.2.1.1. Radiofrequency Ablation/Thermal Ablation

            13.2.1.2. Laser Ablation Devices

            13.2.1.3. Ultrasound Ablation Devices

        13.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection

        13.2.3. Compression Devices/Garments

        13.2.4. Others

    13.3. Market Value Forecast, by Treatment Type, 2017–2031

        13.3.1. Endovenous Ablation

        13.3.2. Sclerotherapy/Adhesion Injection

        13.3.3. Ligation/Stripping

        13.3.4. Supportive Treatment

    13.4. Market Value Forecast, by Disease Type, 2017–2031

        13.4.1. Greater Saphenous Varicose Veins

        13.4.2. Small Saphenous Varicose Veins

        13.4.3. Others

    13.5. Market Value Forecast, by End-user, 2017–2031

        13.5.1. Hospitals & Ambulatory Surgical Centers

        13.5.2. Specialty Clinics

        13.5.3. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis

        13.7.1. By Product

        13.7.2. By Treatment Type

        13.7.3. By Disease Type

        13.7.4. By End-user

        13.7.5. By Country/Sub-region

14. Latin America Varicose Veins Treatment Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value & Volume Forecast, by Product, 2017–2031

        14.2.1. Ablation Devices

            14.2.1.1. Radiofrequency Ablation/Thermal Ablation

            14.2.1.2. Laser Ablation Devices

            14.2.1.3. Ultrasound Ablation Devices

        14.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection

        14.2.3. Compression Devices/Garments

        14.2.4. Others

    14.3. Market Value Forecast, by Treatment Type, 2017–2031

        14.3.1. Endovenous Ablation

        14.3.2. Sclerotherapy/Adhesion Injection

        14.3.3. Ligation/Stripping

        14.3.4. Supportive Treatment

    14.4. Market Value Forecast, by Disease Type, 2017–2031

        14.4.1. Greater Saphenous Varicose Veins

        14.4.2. Small Saphenous Varicose Veins

        14.4.3. Others

    14.5. Market Value Forecast, by End-user, 2017–2031

        14.5.1. Hospitals & Ambulatory Surgical Centers

        14.5.2. Specialty Clinics

        14.5.3. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1. By Product

        14.7.2. By Treatment Type

        14.7.3. By Disease Type

        14.7.4. By End-user

        14.7.5. By Country/Sub-region

15. Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value & Volume Forecast, by Product, 2017–2031

        15.2.1. Ablation Devices

            15.2.1.1. Radiofrequency Ablation/Thermal Ablation

            15.2.1.2. Laser Ablation Devices

            15.2.1.3. Ultrasound Ablation Devices

        15.2.2. Catheters/Kits for Sclerotherapy & Adhesion Injection

        15.2.3. Compression Devices/Garments

        15.2.4. Others

    15.3. Market Value Forecast, by Treatment Type, 2017–2031

        15.3.1. Endovenous Ablation

        15.3.2. Sclerotherapy/Adhesion Injection

        15.3.3. Ligation/Stripping

        15.3.4. Supportive Treatment

    15.4. Market Value Forecast, by Disease Type, 2017–2031

        15.4.1. Greater Saphenous Varicose Veins

        15.4.2. Small Saphenous Varicose Veins

        15.4.3. Others

    15.5. Market Value Forecast, by End-user, 2017–2031

        15.5.1. Hospitals & Ambulatory Surgical Centers

        15.5.2. Specialty Clinics

        15.5.3. Others

    15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1. By Product

        15.7.2. By Treatment Type

        15.7.3. By Disease Type

        15.7.4. By End-user

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player – Competition Matrix (by tier and size of companies)

    16.2. Market Share Analysis/Ranking, by Company, 2021

    16.3. Company Profiles

        16.3.1. AngioDynamics, Inc.

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. Financial Overview

            16.3.1.4. SWOT Analysis

            16.3.1.5. Strategic Overview

        16.3.2. Boston Scientific Corporation (BTG International Inc.)

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. Financial Overview

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. DJO, LLC (Enovis Corporation)

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. Financial Overview

            16.3.3.4. SWOT Analysis

            16.3.3.5. Strategic Overview

        16.3.4. Essity Aktiebolag (publ) (BSN Medical)

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. Financial Overview

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. F Care Systems NV

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. SWOT Analysis

            16.3.5.4. Strategic Overview

        16.3.6. Medtronic plc

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. Financial Overview

            16.3.6.4. SWOT Analysis

            16.3.6.5. Strategic Overview

        16.3.7. Miravas (IPSA Group)

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. SWOT Analysis

            16.3.7.4. Strategic Overview

        16.3.8. Mylan N.V. (Viatris Inc.)

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. Financial Overview

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. SIGVARIS Group

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. SWOT Analysis

            16.3.9.4. Strategic Overview

        16.3.10. Teleflex Incorporated

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Product Portfolio

            16.3.10.3. Financial Overview

            16.3.10.4. SWOT Analysis

            16.3.10.5. Strategic Overview

        16.3.11. VVT Medical

            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.11.2. Product Portfolio

            16.3.11.3. SWOT Analysis

            16.3.11.4. Strategic Overview

        16.3.12. WONTECH Co., Ltd.

            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.12.2. Product Portfolio

            16.3.12.3. SWOT Analysis

List of Tables

Table 01: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031

Table 03: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031

Table 04: Global Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031

Table 05: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031

Table 06: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031

Table 07: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 08: Global Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 09: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 11: North America Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031

Table 12: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031

Table 13: North America Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031

Table 14: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031

Table 15: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031

Table 16: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Europe Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031

Table 20: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031

Table 21: Europe Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031

Table 22: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031

Table 23: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031

Table 24: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 27: Asia Pacific Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031

Table 28: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031

Table 29: Asia Pacific Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031

Table 30: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031

Table 31: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031

Table 32: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 33: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 34: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 35: Latin America Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031

Table 36: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031

Table 37: Latin America Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031

Table 38: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031

Table 39: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031

Table 40: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 41: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 42: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 43: Middle East & Africa Varicose Veins Treatment Market Volume (Units) Forecast, by Product, 2017–2031

Table 44: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Ablation Devices, 2017–2031

Table 45: Middle East & Africa Varicose Veins Treatment Market Volume (Units) Forecast, by Ablation Devices, 2017–2031

Table 46: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2031

Table 47: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2017–2031

Table 48: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031

Figure 02: Global Varicose Veins Treatment Market Attractiveness Analysis, by Product 2022–2031

Figure 03: Global Varicose Veins Treatment Market (US$ Mn), by Ablation Devices, 2017–2031

Figure 04: Global Varicose Veins Treatment Market (US$ Mn), by Catheters/Kits for Sclerotherapy & Adhesion Injection, 2017–2031

Figure 05: Global Varicose Veins Treatment Market (US$ Mn), by Compression Devices/Garments, 2017–2031

Figure 06: Global Varicose Veins Treatment Market (US$ Mn), by Others, 2017–2031

Figure 07: Global Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031

Figure 08: Global Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031

Figure 09: Global Varicose Veins Treatment Market (US$ Mn), by Endovenous Ablation, 2017–2031

Figure 10: Global Varicose Veins Treatment Market (US$ Mn), by Sclerotherapy/Adhesion Injection, 2017–2031

Figure 11: Global Varicose Veins Treatment Market (US$ Mn), by Ligation/Stripping, 2017–2031

Figure 12: Global Varicose Veins Treatment Market (US$ Mn), by Others, 2017–2031

Figure 13: Global Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031

Figure 14: Global Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031

Figure 15: Global Varicose Veins Treatment Market (US$ Mn), by Greater Saphenous Varicose Veins, 2017–2031

Figure 16: Global Varicose Veins Treatment Market (US$ Mn), by Small Saphenous Varicose Veins, 2017–2031

Figure 17: Global Varicose Veins Treatment Market (US$ Mn), by Others, 2017–2031

Figure 18: Global Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 19: Global Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 20: Global Varicose Veins Treatment Market (US$ Mn), by Hospitals & Ambulatory Surgical Centers, 2017–2031

Figure 21: Global Varicose Veins Treatment Market (US$ Mn), by Specialty Clinics, 2017–2031

Figure 22: Global Varicose Veins Treatment Market (US$ Mn), by Others, 2017–2031

Figure 23: Global Varicose Veins Treatment Market Analysis and Forecast, by Region, 2021 and 2031

Figure 24: Global Varicose Veins Treatment Market Attractiveness Analysis, by Region, 2022–2031

Figure 25: North America Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 26: North America Varicose Veins Treatment Market Analysis and Forecast, by Country, 2021 and 2031

Figure 27: North America Varicose Veins Treatment Market Attractiveness Analysis, by Country, 2022–2031

Figure 28: North America Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031

Figure 29: North America Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031

Figure 30: North America Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031

Figure 31: North America Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031

Figure 32: North America Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031

Figure 33: North America Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031

Figure 34: North America Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 35: North America Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 36: Europe Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 37: Europe Varicose Veins Treatment Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

Figure 38: Europe Varicose Veins Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 39: Europe Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031

Figure 40: Europe Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031

Figure 41: Europe Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031

Figure 42: Europe Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031

Figure 43: Europe Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031

Figure 44: Europe Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031

Figure 45: Europe Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 46: Europe Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 47: Asia Pacific Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 48: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

Figure 49: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 50: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031

Figure 51: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031

Figure 52: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031

Figure 53: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031

Figure 54: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031

Figure 55: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031

Figure 56: Asia Pacific Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 57: Asia Pacific Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 58: Latin America Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 59: Latin America Varicose Veins Treatment Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

Figure 60: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 61: Latin America Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031

Figure 62: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031

Figure 63: Latin America Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031

Figure 64: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031

Figure 65: Latin America Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031

Figure 66: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031

Figure 67: Latin America Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 68: Latin America Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 69: Middle East & Africa Varicose Veins Treatment Market Value (US$ Mn) Forecast, 2017–2031

Figure 70: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031

Figure 71: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 72: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by Product, 2021 and 2031

Figure 73: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by Product, 2022–2031

Figure 74: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by Treatment Type, 2021 and 2031

Figure 75: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by Treatment Type, 2022–2031

Figure 76: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by Disease Type, 2021 and 2031

Figure 77: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by Disease Type, 2022–2031

Figure 78: Middle East & Africa Varicose Veins Treatment Market Analysis and Forecast, by End-user, 2021 and 2031

Figure 79: Middle East & Africa Varicose Veins Treatment Market Attractiveness Analysis, by End-user, 2022–2031

Figure 80: Global Varicose Veins Treatment Market Share Analysis/Ranking, by Company, 2021

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

544

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved